PushCART Therapeutics
PushCART Therapeutics is a developer of cell therapies targeting tumors, advancing innovative biotechnology for improved cancer treatment.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredJun 26, 2026 (5 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — |
Timeline
- Website created
Companies like PushCART Therapeutics
NNormunity$75M Series B+ · Jan 2025
AA2 Biotherapeutics$80M Series B+ · Jan 2025
FFoRx Therapeutics$50M Series A · Dec 2025
AAffini-T$175M Series A · Mar 2022
CCatalYm$150M Series B+ · Jul 2024
AAsta Bio
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/pushcart-therapeutics (get a free API key).